No coin nor oath required. For personal study only.
The Chair made some brief introductory remarks explaining the origin of the movement which had resulted in this joint meeting.
The Chair announced that the first order of business would be the reading of reports of the committees which would logically report to a section of this kind.
The first thing on the program, was the report from the Chairman of the U. S. Committee of Revision of the Pharmacopoeia, Prof. J. P. Remington, but as he
had not yet arrived, the second report on the program would be taken up, namely, that of the Committee on National Formulary, which would be presented by Prof. W. L. Scoville, in the absence of the Chairman of the committee, Prof. C. Lewis Diehl.
The Chair stated that inasmuch as the report embodied a recommendation, and the next paper on the program, "Points of Contact Between the U. S. P. and N.
F." bore directly on that recommendation, he thought it would be well to listen to that paper before taking action, and he would call on the author, E. Fullerton Cook, of Philadelphia, to present it. The Chair said the papers just read before the Section were open for discussion.
C. E. Vanderkleed moved that the report be accepted, and that the recommendation contained therein be approved by the joint meeting. H e added that of course it was understood that this meeting had absolutely no control over the matter, and could only recommend.
H. V. Amy, in seconding this motion, called attention to the fact that Prof.
Diehl, Chairman of the committee, had made two recommendations, and he supposed Mr. Vanderkleed's motion referred to the one which recommended deferrring publication of the National Formulary until after the Pharmacopoeia was published. Mr. Vanderkleed replied in the affirmative, and said this was given preference in the report.
Thereupon, the motion to receive and adopt was put to a vote and carried.
*Now known as the Section on Pharmacopccias and Formularies. Papers and Reports
📜 SIMILAR VOLUMES